ASBP · Aspire Biopharma Holdings, Inc.
$8.87
-0.38 (-4.11%)
At close · Sep 4
View the 10-Q filed Aug 13, 2026
Customer concentration
— top customer 15% of revenue
One customer — 15% of revenue (the six months ended June 30, 2026)
“One customer accounted for approximately 15% of the Company’s total revenues during the six months ended June 30, 2026.”
Market Cap
$12.44M
Shares
1.40M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-12 | 200 | $7.61 | $1,522 |
| 2026-08-11 | 851 | $7.79 | $6,629 |
| 2026-08-04 | 924 | $7.23 | $6,681 |
| 2026-07-31 | 30 | $6.72 | $202 |
| 2026-07-30 | 5,674 | $5.61 | $31,831 |
| 2026-07-29 | 1,211 | $7.25 | $8,780 |
| 2026-07-28 | 2,563 | $6.97 | $17,864 |
| 2026-07-27 | 3,093 | $7.26 | $22,455 |
| 2026-07-24 | 2,684 | $7.21 | $19,352 |
| 2026-07-23 | 760 | $7.76 | $5,898 |
| 2026-07-22 | 2,479 | $7.54 | $18,692 |
| 2026-07-21 | 3,151 | $6.58 | $20,734 |
| 2026-07-17 | 2,868 | $6.28 | $18,011 |
| 2026-07-14 | 370 | $5.97 | $2,209 |
| 2026-07-06 | 1,955 | $6.21 | $12,141 |
| 2026-07-02 | 3,190 | $5.86 | $18,693 |
| 2026-07-01 | 18,290 | $5.34 | $97,669 |
| 2026-06-25 | 3,203 | $6.54 | $20,948 |
| 2026-06-24 | 2,018 | $6.17 | $12,451 |
| 2026-06-23 | 9,196 | $6.29 | $57,843 |
| 2026-06-22 | 27,857 | $6.58 | $183,299 |
| 2026-06-18 | 20,413 | $6.36 | $129,827 |
| 2026-06-17 | 52,527 | $6.19 | $325,142 |
| 2026-06-16 | 112,467 | $5.65 | $635,439 |
| 2026-06-15 | 199,207 | $4.96 | $988,067 |
| 2026-06-12 | 28,362 | $6.00 | $170,172 |
| 2026-06-11 | 11,924 | $5.61 | $66,894 |
| 2026-06-10 | 21,409 | $5.97 | $127,812 |
| 2026-06-09 | 14,678 | $6.65 | $97,609 |
Showing 1–29 of 29 settlements